Comparative Changes of Lipid Levels in Treatment-Naive, HIV-1-Infected Adults Treated with Dolutegravir vs. Efavirenz, Raltegravir, and Ritonavir-Boosted Darunavir-Based Regimens Over 48 Weeks

BACKGROUND AND OBJECTIVES: Long-term use of antiretroviral therapy (ART) to treat HIV infection has been associated with dyslipidemia and metabolic and cardiovascular complications. Available options for patients at risk of cardiovascular disease include antiretroviral drugs with improved lipid prof...

Descripción completa

Detalles Bibliográficos
Autores principales: Quercia, Romina, Roberts, Jeremy, Martin-Carpenter, Louise, Zala, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335094/
https://www.ncbi.nlm.nih.gov/pubmed/25637061
http://dx.doi.org/10.1007/s40261-014-0266-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335094/
https://www.ncbi.nlm.nih.gov/pubmed/25637061
http://dx.doi.org/10.1007/s40261-014-0266-2

Ejemplares similares